Takeda Abbott Pharmaceuticals Sues Atrix
The Eligard products use Atrix's proprietary Atrigel sustained-release drug delivery technology, Atrix said. The liquid Eligard products are injected subcutaneously with a small gauge needle forming a solid implant in the body that slowly releases leuprolide as the implant is bioabsorbed.
Atrix chief executive David...
To view the full article, register now.
Try Law360 FREE for seven days
Already a subscriber? Click here to login